logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11904145 B1

PDFFull Text
Date of Patent:
Feb. 20, 2024

Filed:

Oct. 26, 2021

Diabetes therapy management systems, methods, and devices

Applicant:

Bigfoot Biomedical, Inc., Milpitas, CA (US);

Inventors:

John Sjolund, Los Altos, CA (US);

Ambika Srinath, San Francisco, CA (US);

Andrew Bochenko, Redwood City, CA (US);

George Crothall, Oceanside, CA (US);

Bryan Mazlish, Palo Alto, CA (US);

Lane Desborough, Thousand Oaks, CA (US);

Jennifer Martin Block, Menlo Park, CA (US);

Sarah Matarese, San Jose, CA (US);

Linda Mackowiak, Cazenovia, NY (US);

Assignee:

Bigfoot Biomedical, Inc., Milpitas, CA (US);

Attorney:

TraskBritt

Primary Examiner:

Deanna K Hall

Int. Cl.
CPC ...
A61B 5/00 (2006.01); A61M 5/315 (2006.01); G16H 20/17 (2018.01); A61B 5/145 (2006.01); A61M 5/20 (2006.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); G16H 40/63 (2018.01); G16H 20/60 (2018.01); A61M 5/168 (2006.01); G16H 40/67 (2018.01); G16H 20/13 (2018.01); A61K 38/28 (2006.01); A61M 5/32 (2006.01); A61M 5/00 (2006.01); A61M 5/142 (2006.01); A61M 5/24 (2006.01); A61M 5/31 (2006.01);
U.S. Cl.
CPC ...
A61M 5/31546 (2013.01); A61B 5/0004 (2013.01); A61B 5/14532 (2013.01); A61B 5/4836 (2013.01); A61B 5/4839 (2013.01); A61B 5/7405 (2013.01); A61B 5/746 (2013.01); A61B 5/7435 (2013.01); A61B 5/7455 (2013.01); A61K 38/28 (2013.01); A61M 5/003 (2013.01); A61M 5/168 (2013.01); A61M 5/20 (2013.01); A61M 5/31525 (2013.01); A61M 5/3202 (2013.01); G16H 20/13 (2018.01); G16H 20/17 (2018.01); G16H 20/60 (2018.01); G16H 40/63 (2018.01); G16H 40/67 (2018.01); G16H 50/20 (2018.01); G16H 50/30 (2018.01); A61B 5/14546 (2013.01); A61B 5/681 (2013.01); A61M 5/24 (2013.01); A61M 2005/14208 (2013.01); A61M 2005/2006 (2013.01); A61M 2005/3125 (2013.01); A61M 2205/18 (2013.01); A61M 2205/3306 (2013.01); A61M 2205/3561 (2013.01); A61M 2205/3584 (2013.01); A61M 2205/502 (2013.01); A61M 2205/505 (2013.01); A61M 2205/581 (2013.01); A61M 2205/582 (2013.01); A61M 2205/583 (2013.01); A61M 2209/06 (2013.01); A61M 2230/201 (2013.01);
Abstract

Diabetes management systems include an insulin delivery device and a monitoring device for detecting at least one characteristic relating to the insulin delivery device. Monitoring devices may comprise pen caps.

Find Patent Forward Citations

Quick Actions:

Sjolund, John. (2024). Diabetes therapy management systems, methods, and devices (U.S. Patent No. 11904145). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/11904145

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…